milnacipran has been researched along with Glossalgia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aleksic, B; Arao, M; Iritani, S; Ishihara, R; Kimura, H; Kurita, K; Ozaki, N; Ukai, K; Yamauchi, A | 1 |
| Higuchi, H; Kamata, M; Naito, S; Takahashi, H | 1 |
2 other study(ies) available for milnacipran and Glossalgia
| Article | Year |
|---|---|
Effectiveness of low-dose milnacipran for a patient suffering from pain disorder with delusional disorder (somatic type) in the orofacial region.
Topics: Burning Mouth Syndrome; Cyclopropanes; Dose-Response Relationship, Drug; Female; Glossalgia; Humans; Milnacipran; Schizophrenia, Paranoid; Somatoform Disorders; Treatment Outcome | 2013 |
Milnacipran for the treatment of chronic pain.
Topics: Adrenergic Uptake Inhibitors; Aged; Antidepressive Agents, Tricyclic; Chronic Disease; Cyclopropanes; Female; Glossalgia; Humans; Milnacipran; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2003 |